This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Other skin disorders
  • /
  • NICE approval of adalimumab for moderate-to-severe...
Journal

NICE approval of adalimumab for moderate-to-severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics?

Read time: 1 mins
Published:1st Feb 2017
Author: Ingram JR, Burton T.
Availability: Pay for access, or by subscription
Ref.:Br J Dermatol. 2017;176:281�282.
DOI:10.1111/bjd.15255.
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest